TipRanks Black Friday Sale
- Claim 60% off TipRanks Premium for the data-backed insights and research tools you need to invest with confidence.
- Subscribe to TipRanks' Smart Investor Picks and see our data in action through our high-performing model portfolio - now also 60% off
EBR Systems, Inc. Shs Chess Depository Interests Repr 1 Sh ( (AU:EBR) ) has issued an announcement.
EBR Systems, Inc. has announced an investor roadshow in Australia from November 4 to November 6, 2025, offering securityholders a chance to engage with the company’s Chief Corporate Development Officer, Andrew Shute, and an Australian-based implanter. The roadshow will provide updates on recent milestones and insights into the commercialization pathway of EBR’s innovative wireless cardiac pacing technology. This initiative reflects EBR’s commitment to enhancing stakeholder engagement and expanding its market presence, potentially impacting its industry positioning by showcasing its cutting-edge technology and future applications.
The most recent analyst rating on (AU:EBR) stock is a Buy with a A$2.48 price target. To see the full list of analyst forecasts on EBR Systems, Inc. Shs Chess Depository Interests Repr 1 Sh stock, see the AU:EBR Stock Forecast page.
More about EBR Systems, Inc. Shs Chess Depository Interests Repr 1 Sh
Silicon Valley-based EBR Systems, Inc. is a pioneering company in the cardiac rhythm disease management industry, specializing in wireless cardiac pacing technology. Their proprietary Wireless Stimulation Endocardially (WiSE) technology aims to improve the physiological effectiveness of cardiac stimulation by eliminating the need for traditional pacing leads, which are often associated with complications. EBR’s initial product targets heart failure patients requiring Cardiac Resynchronisation Therapy (CRT) and is currently available in the US, with future plans to expand its applications.
Average Trading Volume: 669,086
Technical Sentiment Signal: Hold
Find detailed analytics on EBR stock on TipRanks’ Stock Analysis page.

